3.26.1 html 233 410 1 false 80 0 false 9 false false R1.htm 75000 - Document - Document And Entity Information Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 75010 - Statement - Consolidated Balance Sheets Sheet http://lyratherapeutics.com/20251231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 75020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 75040 - Statement - Consolidated Statements of Stockholders' Equity (audited) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityAudited Consolidated Statements of Stockholders' Equity (audited) Statements 5 false false R6.htm 75050 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical) (audited) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParentheticalAudited Consolidated Statements of Stockholders' Equity (Parenthetical) (audited) Statements 6 false false R7.htm 75060 - Statement - Consolidated Statements of Cash Flows Sheet http://lyratherapeutics.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 8 false false R9.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 9 false false R10.htm 995457 - Disclosure - Cybersecurity Risk Management, Strategy and Governance Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance Cybersecurity Risk Management, Strategy and Governance Notes 10 false false R11.htm 995467 - Disclosure - Organization, Restructuring, Going Concern and Basis of Presentation Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureOrganizationRestructuringGoingConcernAndBasisOfPresentation1 Organization, Restructuring, Going Concern and Basis of Presentation Notes 11 false false R12.htm 995477 - Disclosure - Summary of Significant Accounting Policies Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 12 false false R13.htm 995487 - Disclosure - Fair Value Measurements Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 995497 - Disclosure - Short-term Investments Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestments1 Short-term Investments Notes 14 false false R15.htm 995507 - Disclosure - Restructuring and Other Related Charges Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedCharges Restructuring and Other Related Charges Notes 15 false false R16.htm 995517 - Disclosure - Property and Equipment and Related Impairment Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentAndRelatedImpairment Property and Equipment and Related Impairment Notes 16 false false R17.htm 995527 - Disclosure - Impairment of Right of Use Assets Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureImpairmentOfRightOfUseAssets Impairment of Right of Use Assets Notes 17 false false R18.htm 995537 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 18 false false R19.htm 995547 - Disclosure - Segment Reporting Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSegmentReporting Segment Reporting Notes 19 false false R20.htm 995557 - Disclosure - Preferred and Common Stock Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosurePreferredAndCommonStock Preferred and Common Stock Notes 20 false false R21.htm 995567 - Disclosure - Common Stock Warrants Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommonStockWarrants Common Stock Warrants Notes 21 false false R22.htm 995577 - Disclosure - Stock-Based Compensation Expense Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationExpense Stock-Based Compensation Expense Notes 22 false false R23.htm 995587 - Disclosure - Collaboration Agreement Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreement Collaboration Agreement Notes 23 false false R24.htm 995597 - Disclosure - Income Taxes Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 24 false false R25.htm 995607 - Disclosure - Leases Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeases Leases Notes 25 false false R26.htm 995617 - Disclosure - Retirement Plan Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureRetirementPlan Retirement Plan Notes 26 false false R27.htm 995627 - Disclosure - Commitment and Contingencies Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommitmentAndContingencies Commitment and Contingencies Notes 27 false false R28.htm 995637 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 28 false false R29.htm 995647 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 29 false false R30.htm 995657 - Disclosure - Fair Value Measurements (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureFairValueMeasurements 30 false false R31.htm 995677 - Disclosure - Restructuring and Other Related Charges (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedChargesTables Restructuring and Other Related Charges (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedCharges 31 false false R32.htm 995687 - Disclosure - Property and Equipment and Related Impairment (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentAndRelatedImpairmentTables Property and Equipment and Related Impairment (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentAndRelatedImpairment 32 false false R33.htm 995697 - Disclosure - Impairment of Right of Use Assets (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureImpairmentOfRightOfUseAssetsTables Impairment of Right of Use Assets (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureImpairmentOfRightOfUseAssets 33 false false R34.htm 995707 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities 34 false false R35.htm 995717 - Disclosure - Segment Reporting (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSegmentReportingTables Segment Reporting (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSegmentReporting 35 false false R36.htm 995727 - Disclosure - Preferred and Common Stock (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosurePreferredAndCommonStockTables Preferred and Common Stock (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosurePreferredAndCommonStock 36 false false R37.htm 995737 - Disclosure - Common Stock Warrants (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommonStockWarrantsTables Common Stock Warrants (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommonStockWarrants 37 false false R38.htm 995747 - Disclosure - Stock-Based Compensation Expense (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseTables Stock-Based Compensation Expense (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationExpense 38 false false R39.htm 995757 - Disclosure - Collaboration Agreement (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreementTables Collaboration Agreement (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreement 39 false false R40.htm 995767 - Disclosure - Income Taxes (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxes 40 false false R41.htm 995777 - Disclosure - Leases (Tables) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeases 41 false false R42.htm 995797 - Disclosure - Organization, Restructuring, Going Concern and Basis of Presentation - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureOrganizationRestructuringGoingConcernAndBasisOfPresentationAdditionalInformationDetails Organization, Restructuring, Going Concern and Basis of Presentation - Additional Information (Details) Details 42 false false R43.htm 995807 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 43 false false R44.htm 995817 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Cash, Cash Equivalents and Restricted Cash Reported within Balance Sheet (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashReportedWithinBalanceSheetDet Summary of Significant Accounting Policies - Summary of Reconciliation of Cash, Cash Equivalents and Restricted Cash Reported within Balance Sheet (Details) Details 44 false false R45.htm 995827 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 45 false false R46.htm 995837 - Disclosure - Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Details 46 false false R47.htm 995847 - Disclosure - Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossPerShareDetails Summary of Significant Accounting Policies - Summary of Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share (Details) Details 47 false false R48.htm 995857 - Disclosure - Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 48 false false R49.htm 995867 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 49 false false R50.htm 995877 - Disclosure - Short-term Investments - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureShorttermInvestmentsAdditionalInformationDetails Short-term Investments - Additional Information (Details) Details 50 false false R51.htm 995887 - Disclosure - Restructuring and Other Related Charges (Additional Information) (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedChargesAdditionalInformationDetails Restructuring and Other Related Charges (Additional Information) (Details) Details http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedChargesTables 51 false false R52.htm 995897 - Disclosure - Restructuring and Other Related Charges - Summary of Restructuring Liability Activities (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureRestructuringAndOtherRelatedChargesSummaryOfRestructuringLiabilityActivitiesDetails Restructuring and Other Related Charges - Summary of Restructuring Liability Activities (Details) Details 52 false false R53.htm 995907 - Disclosure - Property and Equipment and Related Impairment - Schedule of Property and Equipment (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentAndRelatedImpairmentScheduleOfPropertyAndEquipmentDetails Property and Equipment and Related Impairment - Schedule of Property and Equipment (Details) Details 53 false false R54.htm 995917 - Disclosure - Property and Equipment and Related Impairment - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePropertyAndEquipmentAndRelatedImpairmentAdditionalInformationDetails Property and Equipment and Related Impairment - Additional Information (Details) Details 54 false false R55.htm 995927 - Disclosure - Impairment of Right of Use Assets - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureImpairmentOfRightOfUseAssetsAdditionalInformationDetails Impairment of Right of Use Assets - Additional Information (Details) Details 55 false false R56.htm 995937 - Disclosure - Impairment of Right of Use Assets - Schedule of Fair Value Analysis of Right of Use Assets Using Discounted Cash Flow Methodology (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureImpairmentOfRightOfUseAssetsScheduleOfFairValueAnalysisOfRightOfUseAssetsUsingDiscountedCashFlowMethodologyDetails Impairment of Right of Use Assets - Schedule of Fair Value Analysis of Right of Use Assets Using Discounted Cash Flow Methodology (Details) Details 56 false false R57.htm 995947 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 57 false false R58.htm 995967 - Disclosure - Segment Reporting - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSegmentReportingAdditionalInformationDetails Segment Reporting - Additional Information (Details) Details 58 false false R59.htm 995977 - Disclosure - Segment Reporting - Summary of Revenue Significant Expenses and Net Loss for Segment (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureSegmentReportingSummaryOfRevenueSignificantExpensesAndNetLossForSegmentDetails Segment Reporting - Summary of Revenue Significant Expenses and Net Loss for Segment (Details) Details 59 false false R60.htm 995987 - Disclosure - Preferred and Common Stock - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosurePreferredAndCommonStockAdditionalInformationDetails Preferred and Common Stock - Additional Information (Details) Details 60 false false R61.htm 995997 - Disclosure - Preferred and Common Stock - Schedule of Assumptions Used in Black Scholes Model (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosurePreferredAndCommonStockScheduleOfAssumptionsUsedInBlackScholesModelDetails Preferred and Common Stock - Schedule of Assumptions Used in Black Scholes Model (Details) Details 61 false false R62.htm 996007 - Disclosure - Preferred and Common Stock - Schedule of Common Stock Reserved for Future Issuances (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosurePreferredAndCommonStockScheduleOfCommonStockReservedForFutureIssuancesDetails Preferred and Common Stock - Schedule of Common Stock Reserved for Future Issuances (Details) Details 62 false false R63.htm 996017 - Disclosure - Common Stock Warrants - Summary of Warrants Outstanding and Exercisable (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommonStockWarrantsSummaryOfWarrantsOutstandingAndExercisableDetails Common Stock Warrants - Summary of Warrants Outstanding and Exercisable (Details) Details 63 false false R64.htm 996037 - Disclosure - Stock-Based Compensation Expense - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseAdditionalInformationDetails Stock-Based Compensation Expense - Additional Information (Details) Details 64 false false R65.htm 996047 - Disclosure - Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureStockBasedCompensationExpenseScheduleOfStockBasedCompensationExpenseDetails Stock-Based Compensation Expense - Schedule of Stock-Based Compensation Expense (Details) Details 65 false false R66.htm 996057 - Disclosure - Stock-Based Compensation Expense - Summary of Restricted Stock Unit Activity, Including 2024 PSUs (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfRestrictedStockUnitActivityIncluding2024PsusDetails Stock-Based Compensation Expense - Summary of Restricted Stock Unit Activity, Including 2024 PSUs (Details) Details 66 false false R67.htm 996067 - Disclosure - Stock-Based Compensation Expense - Schedule of Unrecognized Stock-Based Compensation (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationExpenseScheduleOfUnrecognizedStockbasedCompensationDetails Stock-Based Compensation Expense - Schedule of Unrecognized Stock-Based Compensation (Details) Details 67 false false R68.htm 996077 - Disclosure - Stock-Based Compensation Expense - Schedule of Fair Value of Stock Option Estimated on Date of Grant Using Black-Scholes Option-Pricing Model or Monte Carlo Simulation in Case of Options Granted to Certain Executive Officers (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationExpenseScheduleOfFairValueOfStockOptionEstimatedOnDateOfGrantUsingBlackscholesOptionpricingModelOrMonteC Stock-Based Compensation Expense - Schedule of Fair Value of Stock Option Estimated on Date of Grant Using Black-Scholes Option-Pricing Model or Monte Carlo Simulation in Case of Options Granted to Certain Executive Officers (Details) Details 68 false false R69.htm 996087 - Disclosure - Stock-Based Compensation Expense - Summary of Stock Option Activity, Including Incentive Options, Under Plans (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureStockbasedCompensationExpenseSummaryOfStockOptionActivityIncludingIncentiveOptionsUnderPlansDetails Stock-Based Compensation Expense - Summary of Stock Option Activity, Including Incentive Options, Under Plans (Details) Details 69 false false R70.htm 996097 - Disclosure - Collaboration Agreement - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreementAdditionalInformationDetails Collaboration Agreement - Additional Information (Details) Details 70 false false R71.htm 996107 - Disclosure - Collaboration Agreement - Summary of Change in the Transaction Price (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreementSummaryOfChangeInTheTransactionPriceDetails Collaboration Agreement - Summary of Change in the Transaction Price (Details) Details 71 false false R72.htm 996117 - Disclosure - Collaboration Agreement - Revenue Recognized Related to Each of the Performance Obligations and the Remaining Deferred Revenue (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCollaborationAgreementRevenueRecognizedRelatedToEachOfThePerformanceObligationsAndTheRemainingDeferredRevenueDetails Collaboration Agreement - Revenue Recognized Related to Each of the Performance Obligations and the Remaining Deferred Revenue (Details) Details 72 false false R73.htm 996127 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 73 false false R74.htm 996137 - Disclosure - Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) Details http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables 74 false false R75.htm 996157 - Disclosure - Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) Details http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureIncomeTaxesTables 75 false false R76.htm 996167 - Disclosure - Leases - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 76 false false R77.htm 996177 - Disclosure - Leases - Schedule of Components of Lease Cost (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeasesScheduleOfComponentsOfLeaseCostDetails Leases - Schedule of Components of Lease Cost (Details) Details 77 false false R78.htm 996187 - Disclosure - Leases - Summary of Weighted-Average Remaining Lease Term and Discount Rate Related to Operating Leases (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeasesSummaryOfWeightedAverageRemainingLeaseTermAndDiscountRateRelatedToOperatingLeasesDetails Leases - Summary of Weighted-Average Remaining Lease Term and Discount Rate Related to Operating Leases (Details) Details 78 false false R79.htm 996197 - Disclosure - Leases - Summary of Maturity of Operating Lease Liabilities (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureLeasesSummaryOfMaturityOfOperatingLeaseLiabilitiesDetails Leases - Summary of Maturity of Operating Lease Liabilities (Details) Details 79 false false R80.htm 996217 - Disclosure - Retirement Plan - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/Role_DisclosureRetirementPlanAdditionalInformationDetails Retirement Plan - Additional Information (Details) Details 80 false false R81.htm 996227 - Disclosure - Commitment and Contingencies - Additional Information (Details) Sheet http://lyratherapeutics.com/20251231/taxonomy/role/DisclosureCommitmentAndContingenciesAdditionalInformationDetails Commitment and Contingencies - Additional Information (Details) Details 81 false false All Reports Book All Reports lyra-20251231.htm lyra-20251231.xsd http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false